Literature DB >> 23438807

Anesthetics, cerebral protection and preconditioning.

Rogean Rodrigues Nunes1, Gastão Fernandes Duval Neto, Júlio César Garcia de Alencar, Suyane Benevides Franco, Nayanna Quezado de Andrade, Danielle Maia Holanda Dumaresq, Sara Lúcia Cavalcante.   

Abstract

BACKGROUND AND OBJECTIVES: Several studies demonstrate that cerebral preconditioning is a protective mechanism against a stressful situation. Preconditioning determinants are described, as well as the neuroprotection provided by anesthetic and non-anesthetics agents. CONTENT: Review based on the main articles addressing the pathophysiology of ischemia-reperfusion and neuronal injury and pharmacological and non-pharmacological factors (inflammation, glycemia, and temperature) related to the change in response to ischemia-reperfusion, in addition to neuroprotection induced by anesthetic use.
CONCLUSIONS: The brain has the ability to protect itself against ischemia when stimulated. The elucidation of this mechanism enables the application of preconditioning inducing substances (some anesthetics), other drugs, and non-pharmacological measures, such as hypothermia, aimed at inducing tolerance to ischemic lesions.
Copyright © 2013 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23438807     DOI: 10.1016/S0034-7094(13)70204-6

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  3 in total

Review 1.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

2.  Sufentanil alleviates cerebral ischemia-reperfusion injury by inhibiting inflammation and protecting the blood-brain barrier in rats.

Authors:  Zhen Wang; Xiaoyan Du; Daoyang Yu; Yang Yang; Gaoen Ma; Xueli Jia; Lulu Cheng
Journal:  Eur J Histochem       Date:  2022-01-12       Impact factor: 3.188

3.  Effect of preconditioning on propofol-induced neurotoxicity during the developmental period.

Authors:  Satoshi Shibuta; Tomotaka Morita; Jun Kosaka
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.